摘要
分析了32例葡萄胎患者化疗前后血清中SIL-2R和TNF含量的变化。结果表明:化疗前血清中SlL-2R和TNF含量均显著地高于正常对照组(P<0.01,P<0.001),化疗后均有明显的下降(P<0.05),SIL-2R和TNF与β-HCG呈正相关(r=0.6263,r=0.6105,P<0.01)。机理不明。结果提示:血清SIL-2R和TNF可作为葡萄胎患者免疫功能监测指标之一,并可作为疗效判断的参考。
During pre-and post chemotherapy SIL-2R and TNF were analyzed in 32 patients with hydatidiform mole. The result showed that prechemotherapy SIL-2R and TNF levels in the patients were higher than those in the controls (P < 0. 01, P< 0. 001 ), post chemotherapy SIL-2R and TNF levels were decreased. (P < 0. 05 ). β-HCG had a positive correlationship with SIL-2R and TNF(r = 0. 6263, r = 0. 6105, P < 0. 01 ), but the mechanism of their correlationship is not clear at present. The results here suggest that the detection of serum level of SIL-2R and TNF might be a useful method of monitoring the immune function in patients with hydatidiform mole.
出处
《标记免疫分析与临床》
CAS
1998年第3期131-133,共3页
Labeled Immunoassays and Clinical Medicine